Jul 15, 2025 / 07:00AM GMT
Fredrik Dalborg - AddLife AB - President, Chief Executive Officer
Good morning, everyone, and a warm welcome to the AddLife Second Quarter Report. Christina and I will take you through the highlights of the report. And after that, we will have a Q&A session, as always. And as you may remember, we like to show you a little bit of a summary of some of our companies.
So this time around, we are -- we have recorded a video with MBA, our Spanish and Portuguese company that are fantastic in orthopedic surgery and now expanding into other fields of advanced surgery and hospital products. But let's get started now with the numbers.
So I'm really pleased to share with you all that the AddLife companies continue to deliver on the priorities that we have set out. And the number one priority, as you may remember, is to improve margins and profit. So we saw a significant margin improvement in both business areas actually. Both Labtech and Medtech achieving a level above 12% EBITA margin. So -- and that's a significant increase for both business areas.
We saw a healthy customer demand
Q2 2025 AddLife AB Earnings Call Transcript
4 days ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers